GTC Biotherapeutics does not receive European approval for its product extracted from transgenic goats’ milk.
|
CEO of GTC Biotherapeutics says his firm is rearing transgenic goats that will lead to a drug to treat blood-clotting problems.
|
This month’s sweet spot was sweet indeed for the market’s transactions. Plus: All you need to know about how well an IPO will do in the aftermarket.
|